Y-mAbs Therapeutics A/S

Y-mAbs Therapeutics A/S is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets based on a range of technologies licensed from Memorial Sloan Kettering Cancer Center under an exclusive worldwide license and research collaboration agreement. YmAbs applies its world-class antibody capabilities to create life-changing immunotherapies for cancer patients of all ages. YmAbs’ innovative product candidates leverage its extensive drug development capabilities and its proprietary protein technology platform – MULTI TAGTM.

Contact name:

Claus J. Møller


Agern Allé 11, 2970 Hørsholm, Denmark


+45 7026 1414

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2017 Danskbiotek. All rights reserved.